These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 31237104)

  • 21. Adalimumab versus Rifampicin Plus Clindamycin for the Treatment of Moderate to Severe Hidradenitis Suppurativa: A Retrospective Study.
    Marasca C; Annunziata MC; Villani A; Volpe S; Marasca D; Fabbrocini G
    J Drugs Dermatol; 2019 May; 18(5):437-438. PubMed ID: 31141853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adalimumab medium-term dosing strategy in moderate-to-severe hidradenitis suppurativa: integrated results from the phase III randomized placebo-controlled PIONEER trials.
    Jemec GBE; Okun MM; Forman SB; Gulliver WPF; Prens EP; Mrowietz U; Armstrong AW; Geng Z; Gu Y; Williams DA; Teixeira HD; Kimball AB
    Br J Dermatol; 2019 Nov; 181(5):967-975. PubMed ID: 30916379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of a combined pharmacological and surgical approach in patients affected by hidradenitis suppurativa: data from a retrospective real-world clinical study.
    Malvaso D; Chiricozzi A; Fossati B; Antonelli F; Peris K
    Ital J Dermatol Venerol; 2024 Apr; 159(2):190-195. PubMed ID: 38650499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LAight® Therapy Significantly Enhances Treatment Efficacy of 16 Weeks of Topical Clindamycin Solution in Hurley I and II Hidradenitis Suppurativa: Results from Period A of RELIEVE, a Multicenter Randomized, Controlled Trial.
    Schultheis M; Staubach P; Nikolakis G; Grabbe S; Ruckes C; von Stebut E; Kirschner U; Matusiak Ł; Szepietowski JC
    Dermatology; 2022; 238(3):476-486. PubMed ID: 34535610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dermal tunnels influence time to clinical response and family history influences time to loss of clinical response in patients with hidradenitis suppurativa treated with adalimumab.
    Frew JW; Jiang CS; Singh N; Grand D; Navrazhina K; Vaughan R; Krueger JG
    Clin Exp Dermatol; 2021 Mar; 46(2):306-313. PubMed ID: 32931599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved clinical effectiveness of adalimumab when initiated with clindamycin and rifampicin in hidradenitis suppurativa.
    Aarts P; van Huijstee JC; van der Zee HH; van Straalen KR; Prens EP
    J Eur Acad Dermatol Venereol; 2024 May; 38(5):904-909. PubMed ID: 38112226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clindamycin and rifampicin combination therapy for hidradenitis suppurativa.
    Mendonça CO; Griffiths CE
    Br J Dermatol; 2006 May; 154(5):977-8. PubMed ID: 16634904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination Therapies for Hidradenitis Suppurativa: A Retrospective Chart Review of 31 Patients.
    McPhie ML; Bridgman AC; Kirchhof MG
    J Cutan Med Surg; 2019; 23(3):270-276. PubMed ID: 30658534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reliability of the hidradenitis suppurativa clinical response in the assessment of patients with hidradenitis suppurativa.
    Kimball AB; Ganguli A; Fleischer A
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2254-2256. PubMed ID: 29959796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Update on Medical Treatment Options for Hidradenitis Suppurativa.
    Deckers IE; Prens EP
    Drugs; 2016 Feb; 76(2):215-29. PubMed ID: 26659474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of piperacillin/tazobactam in the treatment of Hidradenitis suppurativa.
    Barzilai A; Toubiana S; Dalal A; Baum S
    J Dermatolog Treat; 2024 Dec; 35(1):2363318. PubMed ID: 39103159
    [No Abstract]   [Full Text] [Related]  

  • 32. Naevus comedonicus syndrome complicated by hidradenitis suppurativa-like lesions responding to acitretin treatment.
    Qian G; Liu T; Zhou C; Zhang Y
    Acta Derm Venereol; 2015 Nov; 95(8):992-3. PubMed ID: 25758459
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy and safety of topical resorcinol 15% versus topical clindamycin 1% in the management of mild-to-moderate hidradenitis suppurativa: A retrospective study.
    Molinelli E; Brisigotti V; Simonetti O; Sapigni C; D'Agostino GM; Rizzetto G; Giacchetti A; Offidani A
    Dermatol Ther; 2022 Jun; 35(6):e15439. PubMed ID: 35278025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unconventional therapies for hidradenitis suppurativa.
    Marasca C; Annunziata MC; Napolitano M; Fabbrocini G
    Expert Rev Clin Pharmacol; 2018 Sep; 11(9):879-887. PubMed ID: 30136871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working group.
    Zouboulis CC; Bechara FG; Dickinson-Blok JL; Gulliver W; Horváth B; Hughes R; Kimball AB; Kirby B; Martorell A; Podda M; Prens EP; Ring HC; Tzellos T; van der Zee HH; van Straalen KR; Vossen ARJV; Jemec GBE
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):19-31. PubMed ID: 30176066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study.
    Kimball AB; Sobell JM; Zouboulis CC; Gu Y; Williams DA; Sundaram M; Teixeira HD; Jemec GB
    J Eur Acad Dermatol Venereol; 2016 Jun; 30(6):989-94. PubMed ID: 26201313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biologic Treatment for Hidradenitis Suppurativa.
    Flood KS; Porter ML; Kimball AB
    Am J Clin Dermatol; 2019 Oct; 20(5):625-638. PubMed ID: 31140067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of biological treatments in patients with hidradenitis suppurativa.
    Martin-Ezquerra G; Masferrer E; Masferrer-Niubò M; Ferran M; Sánchez-Regaña M; Collgros H; Bordas X; Notario J; Alsina M; Gil I; Izquierdo N; Aparicio G; Mollet J; Garcia-Patos V; Pujol RM
    J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):56-60. PubMed ID: 24629001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients.
    Gener G; Canoui-Poitrine F; Revuz JE; Faye O; Poli F; Gabison G; Pouget F; Viallette C; Wolkenstein P; Bastuji-Garin S
    Dermatology; 2009; 219(2):148-54. PubMed ID: 19590173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients.
    Scheinfeld N
    Dermatol Online J; 2013 Apr; 19(4):1. PubMed ID: 24021361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.